SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alseres Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: james who wrote (530)12/19/1997 10:15:00 PM
From: john e vanden biesen  Read Replies (1) | Respond to of 975
 
BLSI will complete meta analysis of the 3 phase 3 trials (700 pts)
and submit the results to fda for therafectin approval in 98.